Solid Biosciences (SLDB) Shares Outstanding (2017 - 2026)

Solid Biosciences (SLDB) has 9 years of Shares Outstanding (Entity) data on file, last reported at $66.3 million in Q1 2025.

• For the quarter ending Q1 2025, Shares Outstanding (Entity) rose 75.35% year-over-year to $66.3 million; the trailing twelve-month figure through Mar 2025 stood at $66.3 million (up 75.35% YoY), and the FY2024 full-year result was $40.5 million, up 98.5% from the prior year.
• Shares Outstanding (Entity) advanced to $66.3 million in Q1 2025, from $40.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $66.3 million in Q1 2025 to a low of $6.0 million in Q1 2021.
• A 5-year average of $21.3 million and a median of $19.6 million in 2023 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) increased 2.42% in 2022 and surged 166.32% in 2023, its largest moves.
• Tracing SLDB's Shares Outstanding (Entity) over 5 years: stood at $7.4 million in 2021, then climbed by 15.71% to $8.5 million in 2022, then jumped by 139.5% to $20.4 million in 2023, then jumped by 98.5% to $40.5 million in 2024, then soared by 63.93% to $66.3 million in 2025.
• Business Quant data shows SLDB's Shares Outstanding (Entity) at $66.3 million in Q1 2025, $40.5 million in Q4 2024, and $38.9 million in Q3 2024.